BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

552 related articles for article (PubMed ID: 24006213)

  • 21. Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years.
    Maccarrone M; Di Marzo V; Gertsch J; Grether U; Howlett AC; Hua T; Makriyannis A; Piomelli D; Ueda N; van der Stelt M
    Pharmacol Rev; 2023 Sep; 75(5):885-958. PubMed ID: 37164640
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cannabis in cancer care.
    Abrams DI; Guzman M
    Clin Pharmacol Ther; 2015 Jun; 97(6):575-86. PubMed ID: 25777363
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cannabinoid analgesia as a potential new therapeutic option in the treatment of chronic pain.
    Burns TL; Ineck JR
    Ann Pharmacother; 2006 Feb; 40(2):251-60. PubMed ID: 16449552
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The adverse health effects of synthetic cannabinoids with emphasis on psychosis-like effects.
    van Amsterdam J; Brunt T; van den Brink W
    J Psychopharmacol; 2015 Mar; 29(3):254-63. PubMed ID: 25586398
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Medical cannabis: the opportunity versus the temptation].
    Naftali T
    Harefuah; 2011 Dec; 150(12):911-2, 935. PubMed ID: 22352284
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cannabis-based medicinal products: summary of NICE guidance.
    Chang-Douglass S; Mulvihill C; Pilling S;
    BMJ; 2020 Apr; 369():m1108. PubMed ID: 32317246
    [No Abstract]   [Full Text] [Related]  

  • 27. State of the science: cannabis and cannabinoids in palliative medicine-the potential.
    Roychoudhury P; Kapoor AK; Walsh D; Cortes H; Clarke H
    BMJ Support Palliat Care; 2021 Sep; 11(3):299-302. PubMed ID: 33903260
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Perspectives of cannabinoids in gastroenterology].
    Storr M; Yüce B; Göke B
    Z Gastroenterol; 2006 Feb; 44(2):185-91. PubMed ID: 16456761
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cannabis and cannabinoids: pharmacology and therapeutic potential.
    Śmiarowska M; Białecka M; Machoy-Mokrzyńska A
    Neurol Neurochir Pol; 2022; 56(1):4-13. PubMed ID: 35133644
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic Use of Synthetic Cannabinoids: Still an OpenIssue?
    De Luca MA; Fattore L
    Clin Ther; 2018 Sep; 40(9):1457-1466. PubMed ID: 30180974
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of Cannabis and Its Derivatives in Gastrointestinal and Hepatic Disease.
    Gotfried J; Naftali T; Schey R
    Gastroenterology; 2020 Jul; 159(1):62-80. PubMed ID: 32333910
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular Pharmacology of Phytocannabinoids.
    Turner SE; Williams CM; Iversen L; Whalley BJ
    Prog Chem Org Nat Prod; 2017; 103():61-101. PubMed ID: 28120231
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Terpenoids, Cannabimimetic Ligands, beyond the
    Gonçalves ECD; Baldasso GM; Bicca MA; Paes RS; Capasso R; Dutra RC
    Molecules; 2020 Mar; 25(7):. PubMed ID: 32235333
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endogenous cannabinoids revisited: a biochemistry perspective.
    Fonseca BM; Costa MA; Almada M; Correia-da-Silva G; Teixeira NA
    Prostaglandins Other Lipid Mediat; 2013; 102-103():13-30. PubMed ID: 23474290
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic aspects of cannabis and cannabinoids.
    Robson P
    Br J Psychiatry; 2001 Feb; 178():107-15. PubMed ID: 11157423
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cannabis and cannabinoids-easier access, hype and disappointment : What has been confirmed in therapy?].
    Rasche T; Emmert D; Stieber C; Conrad R; Mücke M
    Internist (Berl); 2019 Mar; 60(3):309-314. PubMed ID: 30680416
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The medicinal use of cannabis and cannabinoids--an international cross-sectional survey on administration forms.
    Hazekamp A; Ware MA; Muller-Vahl KR; Abrams D; Grotenhermen F
    J Psychoactive Drugs; 2013; 45(3):199-210. PubMed ID: 24175484
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The future of cannabinoids as analgesic agents: a pharmacologic, pharmacokinetic, and pharmacodynamic overview.
    McCarberg BH; Barkin RL
    Am J Ther; 2007; 14(5):475-83. PubMed ID: 17890938
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cannabinoids in the treatment of pain and spasticity in multiple sclerosis.
    Smith PF
    Curr Opin Investig Drugs; 2002 Jun; 3(6):859-64. PubMed ID: 12137404
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cancer cachexia and cannabinoids.
    Gorter RW
    Forsch Komplementarmed; 1999 Oct; 6 Suppl 3():21-2. PubMed ID: 10575285
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.